GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixinol Wellness Ltd (ASX:EXL) » Definitions » Gross Margin %

Elixinol Wellness (ASX:EXL) Gross Margin % : 38.80% (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Elixinol Wellness Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Elixinol Wellness's Gross Profit for the six months ended in Dec. 2023 was A$1.87 Mil. Elixinol Wellness's Revenue for the six months ended in Dec. 2023 was A$4.81 Mil. Therefore, Elixinol Wellness's Gross Margin % for the quarter that ended in Dec. 2023 was 38.80%.

Warning Sign:

Elixinol Wellness Ltd gross margin has been in long-term decline. The average rate of decline per year is -5.1%.


The historical rank and industry rank for Elixinol Wellness's Gross Margin % or its related term are showing as below:

ASX:EXL' s Gross Margin % Range Over the Past 10 Years
Min: 41.36   Med: 49.17   Max: 57.46
Current: 41.36


During the past 6 years, the highest Gross Margin % of Elixinol Wellness was 57.46%. The lowest was 41.36%. And the median was 49.17%.

ASX:EXL's Gross Margin % is ranked worse than
60.95% of 991 companies
in the Drug Manufacturers industry
Industry Median: 46.47 vs ASX:EXL: 41.36

Elixinol Wellness had a gross margin of 38.80% for the quarter that ended in Dec. 2023 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Elixinol Wellness was -5.10% per year.


Elixinol Wellness Gross Margin % Historical Data

The historical data trend for Elixinol Wellness's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elixinol Wellness Gross Margin % Chart

Elixinol Wellness Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial 57.46 44.41 52.43 45.90 41.36

Elixinol Wellness Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.46 46.18 45.66 44.92 38.80

Competitive Comparison of Elixinol Wellness's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Elixinol Wellness's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elixinol Wellness's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elixinol Wellness's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Elixinol Wellness's Gross Margin % falls into.



Elixinol Wellness Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Elixinol Wellness's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=3.4 / 8.269
=(Revenue - Cost of Goods Sold) / Revenue
=(8.269 - 4.849) / 8.269
=41.36 %

Elixinol Wellness's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=1.9 / 4.814
=(Revenue - Cost of Goods Sold) / Revenue
=(4.814 - 2.946) / 4.814
=38.80 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Elixinol Wellness  (ASX:EXL) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Elixinol Wellness had a gross margin of 38.80% for the quarter that ended in Dec. 2023 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Elixinol Wellness Gross Margin % Related Terms

Thank you for viewing the detailed overview of Elixinol Wellness's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Elixinol Wellness (ASX:EXL) Business Description

Traded in Other Exchanges
Address
680 George Street, Level 12, Sydney, NSW, AUS, 2000
Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the geographical segments of the Americas, Australia, Europe and other regions of which key revenue is derived from the Americas segment. The Americas segment includes the trading results of Elixinol LLC (Elixinol Americas) and its investments and joint ventures in the US through the manufacture and distribution of hemp-derived cannabidiol products.

Elixinol Wellness (ASX:EXL) Headlines

No Headlines